Home / Share Price Target / Themismed
Themis Medicare Share Price Target 2024, 2025, 2026 to 2039 With Charts
Themis Medicare Limited | |||
Symbol: THEMISMED | |||
Price: ₹287.39 | |||
Exchange: NSE | |||
Healthcare -> Drug Manufacturers—Specialty & Generic |
Show Table of Contents
Table of Contents
- 1: Themis Medicare Brief Company Overview
- 1.1: Themis Medicare: A Pharmaceutical Powerhouse
- 1.2: Themis Medicare Financial Performance
- 1.2.1: Is Themis Medicare A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Themis Medicare Share Price Target For 2024
- 2.1.1: Themis Medicare Share Price Target Table For 2024
- 2.1.2: Summary: Themis Medicare Share Price Prediction For 2024
- 2.2: Themis Medicare Share Price Target For 2025
- 2.2.1: Themis Medicare Share Price Target Table For 2025
- 2.2.2: Summary: Themis Medicare Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Themis Medicare Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Themis Medicare Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Themis Medicare Past Performance
Themis Medicare Brief Company Overview
Themis Medicare: A Pharmaceutical Powerhouse
Established in 1952, Themis Medicare is a leading pharmaceutical company based in Mumbai, India. With a global presence, Themis Medicare manufactures and markets a wide range of pharmaceutical products.
Key Products and Services:
- Active Pharmaceutical Ingredients (APIs)
- Formulations for various therapeutic areas
- Generic and branded medicines
Diverse Product Portfolio:
Themis Medicare's diverse product range covers a variety of therapeutic areas, including:
- Anti-tuberculosis
- Anti-malarials
- Cardiology
- Pain management
- Anti-infectives
Industry Reputation:
Themis Medicare has a strong reputation in the pharmaceutical industry, known for its quality products and commitment to healthcare.
Themis Medicare Financial Performance
Metric | Value | Description |
---|---|---|
Market Capital | 1,938.36 Crore | Market valuation of Themis Medicare's shares. |
Revenue (TTM) | 364.04 Crore | Total revenue generated by Themis Medicare over the past twelve months. |
Net Income (TTM) | +45.28 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
Operating Margin | 6.01% | Income from operations as a percentage of revenue, before taxes and interest. |
Profit Margin | 12.43% | Net income as a percentage of revenue, after all expenses. |
Revenue Growth (Quarterly) | -7.1% | Change in revenue compared to the previous quarter. |
Earnings Growth (YOY Quarterly) | -44.7% | Change in earnings compared to the same quarter last year. |
Debt-to-Equity (D/E) Ratio | 25.97 | Company's total debt divided by total shareholder equity. |
Total Debt | 94.58 Crore | Sum of Themis Medicare's current & long-term financial obligations. |
Total Cash | 22.38 Crore | Total amount of liquid funds available to Themis Medicare. |
Beta | 0.6 | Beta is less than 1 indicating that the Themis Medicare's price is less volatile than the market. |
Is Themis Medicare A Good Buy For Long Term?
Themis Medicare, a small-cap stock with a market cap of Rs. 1,962.75 Crore, has shown mixed performance recently. Despite a 12.43% profit margin, it has a concerning -44.7% change in earnings and -7.1% change in revenue. While it has generated strong returns over the past 3, 5, and 12 months, it has a high debt of Rs. 94.58 Crore. Given these factors, it may be considered as an average buy for long-term investment, but investors should proceed with caution and monitor the company's financial performance closely.
To predict the Themis Medicare's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Themis Medicare Share Price Target For 2024
The line chart displays the monthly closing prices of Themis Medicare with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Themis Medicare shares in 2024, see the table below.
Themis Medicare Share Price Target Table For 2024
Themis Medicare's Levels | Value | Reason/Importance |
---|---|---|
2024 Target 3 | 298.95 (+4.02%) | Fibonacci Extension Level 150% |
2024 Target 2 | 293.82 (+2.23%) | Custom Fibonacci Extension Lvl 64.9% |
2024 Target 1 | 289.73 (+0.81%) | Custom Fibonacci Extension Lvl 23.6% |
Current Price | 287.39 | Themis Medicare's 1 share price as of Thu 21 Nov 2024 |
Stop Loss 1 | 286.67 (-0.26%) | Price Action: Chart |
Stop Loss 2 | 283.50 (-1.36%) | Price Action: 19 Nov 2024 Low |
Stop Loss 3 | 280.20 (-2.51%) | Price Action: 12 Nov 2024 High |
Summary: Themis Medicare Share Price Prediction For 2024
In summary, Themis Medicare has surged by ₹73.69, achieving a notable +34.48% increase from 1st January 2024 to 21 Nov 2024. Our analysis of Themis Medicare for 2024 predicts an additional rise of 0.81% to 4.02% by the end of 2024 with three potential targets T1: 289.73, T2: 293.82, T3: 298.95. Stop Loss at SL1: 286.67, SL2: 283.50, SL3: 280.20.
Themis Medicare has a 52-week high of ₹317.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹152.80, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Themis Medicare.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Themis Medicare Share Price Target For 2025
The line chart displays the monthly closing prices of Themis Medicare with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Themis Medicare shares in 2025, see the table below.
Themis Medicare Share Price Target Table For 2025
Themis Medicare's Levels | Value | Reason/Importance |
---|---|---|
2025 Target 3 | 397.31 (+38.24%) | Price Action: Chart |
2025 Target 2 | 389.90 (+35.66%) | Price Action: Chart |
2025 Target 1 | 386.04 (+34.32%) | Custom Fibonacci Extension Lvl 64.9% |
Current Price | 287.39 | Themis Medicare's 1 share price as of Thu 21 Nov 2024 |
Stop Loss 1 | 263.00 (-8.49%) | Price Action: Oct 2024 High |
Stop Loss 2 | 259.40 (-9.74%) | Price Action: Mar 2024 High |
Stop Loss 3 | 255.25 (-11.19%) | Price Action: 01 Nov 2024 Low |
Summary: Themis Medicare Share Price Prediction For 2025
In summary, Themis Medicare has surged by ₹73.69, achieving a notable +34.48% increase from 1st January 2024 to 21 Nov 2024. Our analysis of Themis Medicare for 2025 predicts an additional rise of 34.32% to 38.24% by the end of 2025 with three potential targets T1: 386.04, T2: 389.90, T3: 397.31. Stop Loss at SL1: 263.00, SL2: 259.40, SL3: 255.25.
Themis Medicare has a All-Time high of ₹1834.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹152.80, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Themis Medicare, we have created a specific page for that check here: Themis Medicare Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Themis Medicare Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Themis Medicare share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 13.23% over the next 15 years.
For complete year by year Themis Medicare long term share price target from 2024, 2025 to 2039 check the below table.
Themis Medicare Share Price Target Table From 2024, 2025, 2026 to 2039
Year | Themis Medicare Target | YoY Change % |
---|---|---|
2024 | ₹287.39 | [Current Price] |
2024 | ₹305.56 | 6.32% |
2025 | ₹390.4 | 27.76% |
2026 | ₹466.9 | 19.59% |
2027 | ₹582.46 | 24.75% |
2028 | ₹732.78 | 25.8% |
2029 | ₹802.77 | 9.55% |
2030 | ₹869.69 | 8.33% |
2031 | ₹927.12 | 6.6% |
2032 | ₹1,062.03 | 14.55% |
2033 | ₹1,250.82 | 17.77% |
2034 | ₹1,299.99 | 3.93% |
2035 | ₹1,348.98 | 3.76% |
2036 | ₹1,387.34 | 2.84% |
2037 | ₹1,541.6 | 11.11% |
2038 | ₹1,768.87 | 14.74% |
2039 | ₹1,739.11 | -1.69% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Themis Medicare Past Performance
- In 2000, Themis Medicare opening price was ₹9.6
- As of Thu 21 Nov 2024 the price stands at ₹287.39.
- This represents a Compound Annual Growth Rate (CAGR) of 14.56%.
- In 24 years, an investment of 10,000 would have become ₹2.99 Lakh.
As we wrap up, we hope you like our study on Themis Medicare share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Themis Medicare Share Price History
- Themis Medicare Price Target Tomorrow
- Themis Medicare Dividend History
- Themis Medicare Split History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.